Aditxt, Inc.
ADTX- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001726711
No open-market purchases or sales by Aditxt, Inc. insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $0 in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Aditxt, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 16
- +1 vs. Q3 2022
- Shares held
- 697.5K
- +407.9K (+140.8%) vs. Q3 2022
- Total value
- $805.6K
- −$177.5K (−18.1%) vs. Q3 2022
- New holders
- 3
- 4 more added
- Sold out
- 2
- 4 more reduced
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ADTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $0 |
| Q1 2026 | 9 | $19.8K |
| Q4 2025 | 14 | $48.4K |
| Q3 2025 | 14 | $35.9K |
| Q2 2025 | 13 | $50.5K |
| Q1 2025 | 9 | $213.3K |
| Q4 2024 | 11 | $13.9K |
| Q3 2024 | 13 | $29.7K |
| Q2 2024 | 8 | $23.4K |
| Q1 2024 | 10 | $62.2K |
| Q4 2023 | 11 | $31.2K |
| Q3 2023 | 12 | $826.4K |
| Q2 2023 | 14 | $313.8K |
| Q1 2023 | 15 | $618.3K |
| Q4 2022 | 16 | $805.6K |
| Q3 2022 | 16 | $983.2K |
| Q2 2022 | 28 | $392.5K |
| Q1 2022 | 23 | $1.14M |
| Q4 2021 | 27 | $2.01M |
| Q3 2021 | 25 | $2.48M |
| Q2 2021 | 18 | $1.62M |
| Q1 2021 | 22 | $1.63M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Aditxt, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Sabby Management, LLC | 413,094 | $477.0K | 1.28% | +239,685+138.2% | Added |
| Bank of New York Mellon Corp | 183,612 | $212.0K | 0.00% | +148,644+425.1% | Added |
| State Street Corp | 37,900 | $44.3K | 0.00% | +20.0% | Added |
| Susquehanna International Group, LLP | 32,510 | $38.0K | 0.00% | +32,510 | New |
| StoneX Group Inc. | 12,405 | $14.3K | 0.00% | +12,405 | New |
| Natixis | 10,000 | $11.5K | 0.00% | +10,000 | New |
| Tower Research Capital LLC (TRC) | 4,546 | $5.00K | 0.00% | −1,577−25.8% | Reduced |
| Morgan Stanley | 1,475 | $1.70K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 1,421 | $1.65K | 0.00% | −10,580−88.2% | Reduced |
| Federation des caisses Desjardins du Quebec | 50 | $58 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 396 | $23 | 0.00% | +256+182.9% | Added |
| Wells Fargo & Company | 7 | $8 | 0.00% | 00.0% | Unchanged |
| Valley National Advisers Inc | 50 | $0 | 0.00% | 00.0% | Unchanged |
| Cutler Group LP | 2 | $0 | 0.00% | 00.0% | Unchanged |
| Ronald Blue Trust, Inc. | 22 | $0 | 0.00% | −1,058−98.0% | Reduced |
| IFP Advisors, Inc | 55 | – | – | −2,660−98.0% | Reduced |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −19,739−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| American Portfolios Advisors | – | – | – | – | Not filed |